Thomas A McCormick

Publication Activity (10 Years)

Years Active: 2024-2024
Publications (10 Years): 4

Top Topics

Skeletal Muscle

Glycemic Control

Clinical Practice

Top Venues

BMJ open diabetes research & care

This page only lists publications with an associated author ORCID identifier.

Publications

Thomas A McCormick, Jason Kramer, Elizabeth G Liles, Qiana Amos, John P Martin, John L Adams
Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis. BMJ open diabetes research & care 12 (3) (2024)
Thomas A McCormick, Jason Kramer, Elizabeth G Liles, Qiana Amos, John P Martin, John L Adams
Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis. BMJ open diabetes research & care 12 (3) (2024)
Thomas A McCormick, Jason Kramer, Elizabeth G Liles, Qiana Amos, John P Martin, John L Adams
Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis. BMJ open diabetes research & care 12 (3) (2024)
Thomas A McCormick, Jason Kramer, Elizabeth G Liles, Qiana Amos, John P Martin, John L Adams
Cardiovascular and mortality benefits of sodium-glucose cotransporter-2 inhibitors and glucagon-like peptide 1 receptor agonists as third-step glucose-lowering medicine in patients with type 2 diabetes: a retrospective cohort analysis. BMJ open diabetes research & care 12 (3) (2024)